Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

924.7500 -0.85 (-0.09%)

NSE May 29, 2025 15:50 PM

30.17% Fall from 52W High

Volume: 643.4K

Zydus Lifesciences Ltd.

06 Dec 2023

924.75

-0.09%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives Final Approval from the USFDA for Methylene Blue Injection

More from Zydus Lifesciences Ltd.

Recommended

Market closes higher, Alkem Labs' Q4 net profit rises 4.2% YoY to Rs 305.9 crore

Trendlyne Marketwatch | 29 May 2025, 04:09PM

Nifty 50’s annual winners: Top-performing stocks of the past decade

The Baseline | 29 May 2025, 01:00PM

Earnings Call Transcript - Cadila Healthcare